CORE--BIOMEDICAL INSTRUMENTATION

核心--生物医学仪器

• 批准号: 6564943
• 负责人: Joshua I Goldhaber
• 金额: $ 23.8万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-01-01 至 2002-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6564943
• 关键词: arrhythmia; biomedical facility; sudden cardiac death

The Biomedical Instrumentation Core, under the direction of Dr. Goldhaber, will provide support for the design, assembly and maintenance of instrumentation used in each of the SCOR projects. The Core's physical plant, the UCLA Biomedical Instrument Facility, is housed in the UCLA Center for the Health Sciences Building and is readily accessible to the SCOR investigators. In its capacity as UCLA's Biomedical Instrument Facility, the Core has extensive experience providing biomedical instrumentation services for scientists and physicians. The Core personnel have extensive experience and have designed and constructed many of the instruments currently being utilized by the SCOR investigators. Consequently, the Core is primed to perform an essential troubleshooting function. A major advantage of the Biomedical Instrument Core is its ability to manufacture instrumentation at substantial savings compared to commercially available equipment, and to provide custom- designed equipment which is not commercially available. The added benefit of in-house consultation with the personnel who designed and fabricated the device is also a significant advantage. The anticipated usage of the Core by the various Projects is as follows: Project 1: 15%, Project 2: 25%, Project 3: 5%, Project 4: 30%, and Project 5: 25%.

生物医学仪器核心，在博士的指导下。 Goldhaber将为设计，组装和维护提供支持 每个SCOR项目中使用的仪器。 该芯体的 物理工厂，加州大学洛杉矶分校生物医学仪器设施，是设在 加州大学洛杉矶分校中心的健康科学大楼，并随时访问 向SCOR调查员汇报 作为加州大学洛杉矶分校的生物医学 仪器设施，核心有丰富的经验，提供 为科学家和医生提供生物医学仪器服务。 的 核心人员拥有丰富的经验，设计和 建造了许多目前正在使用的仪器 investigators. 因此，核心已经准备好执行一项重要的 故障排除功能。 生物医学仪器的一个主要优势 核心是它能够在大量节省制造仪器 与商业上可用的设备相比，并提供定制- 设计的设备，而不是商业上可用的。 增加 与设计人员进行内部协商的好处， 制造该器件也是一个显著的优点。 预期 各项目对核心的使用情况如下：项目1：15%， 项目2：25%，项目3：5%，项目4：30%，项目5：25%。